| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.5M | +1.6% | +9.2% |
| Cost of Revenue | $7.2M | +15.0% | -23.6% |
| Gross Profit | $3.2M | -19.5% | +3462.2% |
| R&D Expense | $542K | -6.7% | -13.6% |
| SG&A Expense | $4.6M | -5.7% | -6.5% |
| Operating Income | -$4.0M | -18.6% | +45.9% |
| Pre-tax Income | -$4.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.2M | -2.2% | -47.9% |
| Short-term Investments | $18.9M | -8.7% | -26.0% |
| Accounts Receivable | $5.1M | -0.1% | +11.5% |
| Inventory | $6.9M | -9.1% | -9.9% |
| Current Assets | $36.6M | -3.9% | -20.4% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.2M | — | — |
| Capital Expenditures | $800K | — | — |
| Investing Cash Flow | $7.5M | — | — |
| Financing Cash Flow | $188K | — | — |
| Free Cash Flow | -$9.0M | — | — |
| -18.5% |
| +44.4% |
| Income Tax | $79K | +315.8% | +1087.5% |
| Net Income | -$4.3M | -20.1% | +43.3% |
| EPS (Basic) | -$0.08 | -14.3% | +46.7% |
| EPS (Diluted) | -$0.08 | -14.3% | +46.7% |
| $107.6M |
| -2.6% |
| -13.3% |
| Current Liabilities | $6.9M | +7.1% | -28.6% |
| Long-term Debt | $13.1M | +0.3% | +20.4% |
| Total Liabilities | $35.0M | +1.6% | -5.0% |
| Stockholders' Equity | $72.7M | -4.5% | -16.8% |